Glucocorticoid activity, inactivity and the osteoblast

Journal of Endocrinology

Volumn 163, Issue 2, 1999, Pages 159-164

  Cooper, M S ^a   Hewison, M ^a   Stewart, P M ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; COLLAGEN; COLLAGENASE; CORTISONE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LYMPHOTOXIN; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; ONCOPROTEIN; OSTEOCALCIN; PREDNISOLONE; PROTEIN C FOS; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

BONE DENSITY; BONE DEVELOPMENT; BONE MARROW CELL; BONE MATRIX; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG INHIBITION; DRUG MECHANISM; FRACTURE; HUMAN; IN VITRO STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; TRANSLATION REGULATION;

EID: 0032716911     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1630159     Document Type: Review

References (33)

1. Bamberger CM, Schulte HM & Chrousos GP 1496 Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocrine Reviews 17 245-261.
2. Bellows CG, Heersche JNM & Aubin JE 1990 Determination of the capacity for proliferation and differentiation of osteoprogenitor cells in the presence and absence ot dexamethasone. Developmental Biology 140 132-138.
3. Bland R, Worker CA, Noble BS, Eyre LJ, Bujalska IJ, Sheppard MC, Stewart PM & Hewison M 1999 Characterization of 11β-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteoblastic cells. Journal of Endocrinology 161 455-464.
4. Boden SD, McCuaig K, Hair G, Racine M, Titus L, Wozney JM & Nanes MS 1996 Differential effects and glucocorticoid potentiation of bone morphogenetic protein action during rat osteoblast differentiation in vitro. Endocrinology 137 3401-3407.
5. Boden SD, Hair G, Titus L, Racine M, McCuaig K, Wozney JM & Nanes MS 1997 Glucocorticoid-induced differentiation of fetal rat calvarial osteoblasts is mediated by bone morphogenetic protein-6. Endocrinology 138 2820-2828.
6. Bord S, Horner A, Hembry RM, Reynolds JJ & Compston JE 1996 Production of collagenase by human osteoblasts and osteoclasts in vivo. Bone 19 33-40.
7. Bujalska IJ, Kumar S & Stewart PM 1997 Does central obesity reflect 'Cushing's disease of the omentum'? Lancet 349 1210-1213.
8. Canalis E 1996 Clinical review 83. Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. Journal of Clinical Endocrinology and Metabolism 81 3441-3447.
9. Centrella M, McCarthy TL & Canalis E 1991 Glucocorticoid regulation of transforming growth factor-β1 activity and binding in osteoblast-enriched cultures from fetal rat cone. Molecular and Cellular Biology 11 4490-4496.
10. Chambers TJ & Fuller K 1985 Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic attack. Journal of Cell Science 76 155-165.
11. Chang DJ, Ji C, Kim K, Casinghino S, McCarthy TL & Centrella M 1998 Reduction in transforming growth factor β receptor 1 expression and transcription factor CBFa1 on bone cells by glucocorticoid. Journal of Biological Chemistry 273 4892-4896.
12. Chen TL, Chang LY, Bates RL & Perlman AJ 1991 Dexamethasone and 1,25-dihydroxyvitamin D3 modulation of insulin-like growth factor-binding proteins in rat osteoblast-like cell cultures. Endocrinology 128 73-80.
13. Cheng SL, Yang JW, Rifas L, Zhang S & Avioli LV 1994 Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134 277-286.
14. Condon J, Gosden C, Gardener D, Nickson P, Hewison M, Howie AJ & Stewart PM 1998 Expression of type 2 11β-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early fetal life. Journal of Clinical Endocrinology and Metabolism 83 4490-4497.
15. Cooper MS, Ricketts ML, Verhaeg JM, Mangham CD, Hewison M & Stewart PM 1998 Expression and activity of 11β-hydroxysteroid dehydrogenases in human bone and cartilage. Journal of Endocrinology 159 (Suppl) P3.
16. Cooper MS, Hewison M & Stewart PM 1999 Cytokine inhibition of 11β-hydroxysteroid dehydrogenase type 2 in osteoblasts: a novel autocrine anti-inflammatory mechanism. Journal of Endocrinology 160 (Suppl) P225.
17. Cushing HW 1912 The Pituitary Body and in Disorders. Philadelphia: JB Lippincott.
18. Delany AM, Dong Y & Canalis E 1994 Mechanisms of glucocorticoid action in bone cells. Journal of Cellular Biochemistry 56 295-302.
19. Delany AM, Jeffrey JJ, Rydziel S & Canalis E 1995 Cortisol increases interstitial collagenase expression in osteoblasts by posttranscriptional mechanisms. Journal of Biological Chemistry 270 26607-26612.
20. Eastell R 1995 Management of corticosteroid-induced osteoporosis. Journal of Internal Medicine 237 439-447.
21. Grigonadis AE, Schellander K, Wang ZQ & Wagner EF 1993 Osteoblasts are target cells for transformation in c-fos transgenic mice. Journal of Cell Biology 122 685-701.
22. Gronowicz GA, Fall PM & Raisz LG 1994 Prostaglandin E2 stimulates preosteoblast replication: an autoradiographic study in cultured fetal rat calvariae. Experimental Cell Research 212 314-320.
23. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S & Kishimoto T 1997 Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 755-764.
24. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CRW, Seckl JR & Mullins JJ 1997 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proceedings of the National Academy of Sciences of the USA 94 14924-14929.
25. Nakashima T, Sasaki H, Tsuboi M, Kawakami A, Fujiyama K, Kinyama T, Eguchi K, Ichikawa M & Nagataki S 1998 Inhibitory effect of glucocorticoid for osteoblast apoptosis induced by activated peripheral blood mononuclear cells. Endocrinology 139 2032-2040.
26. Oursler MJ, Riggs BL & Conover CA 1993 Glucocorticoid-induced activation of latent transforming growth factor-β by normal human osteoblast-like cells. Endocrinology 133 2187-2196.
27. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS & Kazhdan I 1994 Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Developmental Biology 161 218-228.
28. Sakou T 1998 Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22 591-603.
29. Simmons DJ, Kidder L & Thomas M 1990 Effect of cortisone on cells at the bone-marrow interface. Calcified Tissues International 46 327-332.
30. Stewart PM, Krozowski ZS, Gupta A, Milford DV, Howie AJ, Sheppard MC & Whorwood CB 1996 Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 gene. Lancet 347 88-91.
31. Stromstedt PE, Poellinger L, Gustafsson JA & Carlstedt-Duke J 1991 The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation. Molecular and Cell Biology 11 3379-3383.
32. Weinstein RS, Jilka RL, Parfitt M & Manolagas SC 1998 Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Journal of Clinical Investigation 102 274-282.
33. White PC, Mune T & Agarwal AK 1997 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocrine Reviews 18 135-156.